\-\ Texto\\:\\ \ \(0\)\
\-\ 1\\.\\ nuclear\\ cardiology\\ procedure\\ \\-\\ twenty\\ minutes\\ following\\ injection\\ of\\ tl\\-201\\ at\\ rest\\,\\ a\\ single\\ photon\\ computed\\ tomographic\\ \\(spect\\)\\ image\\ of\\ the\\ myocardium\\ was\\ acquired\\.\\ \\ after\\ review\\ of\\ the\\ patient\\'s\\ blood\\ pressure\\,\\ cardiac\\ and\\ respiratory\\ \ \(0\)\
\-\ findings\\,\\ and\\ ecg\\ the\\ adenosine\\ infusion\\ was\\ initiated\\.\\ following\\ the\\ second\\ minute\\ of\\ the\\ adenosine\\ infusion\\,\\ the\\ tc\\-99\\ tetrofosmin\\ was\\ injected\\.\\ thirty\\ minutes\\ later\\,\\ an\\ r\\-wave\\ gated\\ spect\\ image\\ of\\ the\\ myocardium\\ was\\ acquired\\.\\ images\\ were\\ reviewed\\ on\\ a\\ computer\\ monitor\\ using\\ contrast\\ manipulation\\ techniques\\ and\\ functional\\ imaging\\ correlation\\.\ \(0\)\
\-\ 2\\.\\ cardiac\\ monitoring\\ \\-\\ during\\ the\\ infusion\\ of\\ adenosine\\,\\ the\\ patient\\'s\\ heart\\ rate\\ increased\\ by\\ 6\\ bpm\\ and\\ the\\ systolic\\ blood\\ pressure\\ decreased\\ by\\ 9\\ mmhg\\.\\ symptoms\\ or\\ side\\-effects\\ of\\ mild\\ shortness\\ of\\ breath\\ were\\ observed\\.\\ the\\ baseline\\ ecg\\ revealed\\ lbbb\\ \\(pacer\\ and\\ defibrillator\\ in\\ place\\)\\.\\ \\ the\\ adenosine\\ ecg\\ revealed\\ lbbb\\ with\\ frequency\\ pvcs\\.\ \(0\)\
\-\ this\\ patient\\ has\\ history\\ of\\ remote\\ cabg\\ but\\ no\\ recent\\ functional\\ imaging\\ before\\ the\\ current\\ study\\.\\ \\ while\\ a\\ non\\-reversible\\ perfusion\\ deficit\\ by\\ dual\\ radioisotope\\ nuclear\\ cardiology\\ may\\ prompt\\ a\\ viability\\ study\\ in\\ some\\ patients\\,\\ the\\ presence\\ of\\ a\\ calcified\\ ventricular\\ aneurysm\\ precludes\\ viability\\ of\\ the\\ myocardium\\.\ \(0\)\
\-\ 1\\.\\ the\\ perfusion\\ images\\ reveal\\ severe\\ perfusion\\ deficits\\ of\\ the\\ apex\\,\\ septum\\ \\(base\\ to\\ apex\\)\\,\\ anterior\\ wall\\ \\(apex\\ to\\ mid\\)\\,\\ inferior\\ septal\\ wall\\ \\(apex\\ to\\ base\\)\\ and\\ inferior\\ apical\\ wall\\ of\\ the\\ left\\ ventricular\\ myocardium\\.\\ \\ none\\ of\\ these\\ defects\\ is\\ reversed\\ on\\ rest\\ images\\.\\ left\\ ventricule\\ is\\ fixed\\ and\\ dilated\\.\\ there\\ is\\ severe\\ global\\ hypokinesis\\ with\\ akinesis\\ of\\ the\\ septum\\.\\ the\\ left\\ ventricular\\ ejection\\ fraction\\ is\\ calculated\\ at\\ 14\\%\\ \\(normal\\:\\ \\>45\\%\\)\\,\\ which\\ corresponds\\ with\\ the\\ visual\\ estimate\\.\\ different\\ color\\ schemes\\ allow\\ for\\ alteration\\ of\\ the\\ sensitivity\\ and\\ specificity\\ of\\ the\\ study\\ for\\ myocardial\\ perfusion\\ defects\\.\ \(0\)\
\-\ 2\\.\\ circular\\ calcification\\ of\\ the\\ left\\ ventricular\\ wall\\ consistent\\ with\\ a\\ calcified\\ ventricular\\ aneurysm\\.\ \(0\)\
\-\ myocardial\\ infarction\\ with\\ ventricular\\ aneurysm\ \(0\)\
\-\ myocardial\\ infarction\ \(21\)\
\-\ hibernating\\ myocardium\ \(0\)\
\-\ ventricular\\ aneurysm\ \(7\)\
\-\ a\\ 71\\ year\\-old\\ male\\ with\\ history\\ of\\ cabg\\ in\\ 1980\\.\\ please\\ assess\\ for\\ ischemia\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ myocardium\\:\\ 0\\.09041385036380162\ \(0\)\
\-\ adenosine\\:\\ 0\\.08876908462739402\ \(0\)\
\-\ ventricular\\:\\ 0\\.07302771325523684\ \(0\)\
\-\ perfusion\\:\\ 0\\.053161472190000766\ \(0\)\
\-\ lbbb\\:\\ 0\\.048172231824953546\ \(0\)\
\-\ ecg\\:\\ 0\\.04812360200655785\ \(0\)\
\-\ apex\\:\\ 0\\.04805112367398798\ \(0\)\
\-\ infusion\\:\\ 0\\.04587411966474014\ \(0\)\
\-\ myocardial\\:\\ 0\\.04288524168451138\ \(0\)\
\-\ viability\\:\\ 0\\.042168885985237096\ \(0\)\
\-\ aneurysm\\:\\ 0\\.03691190289664812\ \(0\)\
\-\ cabg\\:\\ 0\\.03128128945687531\ \(0\)\
\-\ spect\\:\\ 0\\.031038383650477314\ \(0\)\
\-\ cardiology\\:\\ 0\\.030368425606256917\ \(0\)\
\-\ wall\\:\\ 0\\.02705091934687154\ \(0\)\
\-\ functional\\:\\ 0\\.02570844021744911\ \(0\)\
\-\ acquired\\:\\ 0\\.025035037810760868\ \(0\)\
\-\ minutes\\:\\ 0\\.024158848466087755\ \(0\)\
\-\ nuclear\\:\\ 0\\.02409179877979369\ \(0\)\
\-\ tc\\-99\\:\\ 0\\.024086115912476773\ \(0\)\
\-\ r\\-wave\\:\\ 0\\.024086115912476773\ \(0\)\
\-\ non\\-reversible\\:\\ 0\\.024086115912476773\ \(0\)\
\-\ ventricule\\:\\ 0\\.024086115912476773\ \(0\)\
\-\ akinesis\\:\\ 0\\.024086115912476773\ \(0\)\
\-\ 1980\\.\\:\\ 0\\.024086115912476773\ \(0\)\
\-\ septum\\:\\ 0\\.023895449002602084\ \(0\)\
\-\ study\\:\\ 0\\.023046158662786552\ \(0\)\
\-\ tl\\-201\\:\\ 0\\.022192271156848506\ \(0\)\
\-\ tetrofosmin\\:\\ 0\\.022192271156848506\ \(0\)\
\-\ side\\-effects\\:\\ 0\\.022192271156848506\ \(0\)\
\-\ hibernating\\:\\ 0\\.022192271156848506\ \(0\)\
\-\ rest\\:\\ 0\\.02153180929379971\ \(0\)\
\-\ defects\\:\\ 0\\.02144901254505325\ \(0\)\
\-\ pvcs\\:\\ 0\\.021084442992618548\ \(0\)\
\-\ precludes\\:\\ 0\\.021084442992618548\ \(0\)\
\-\ schemes\\:\\ 0\\.021084442992618548\ \(0\)\
\-\ radioisotope\\:\\ 0\\.02029842640122024\ \(0\)\
\-\ hypokinesis\\:\\ 0\\.02029842640122024\ \(0\)\
\-\ calcified\\:\\ 0\\.020043846705754344\ \(0\)\
\-\ pacer\\:\\ 0\\.019688744567028408\ \(0\)\
\-\ defibrillator\\:\\ 0\\.019688744567028408\ \(0\)\
\-\ estimate\\:\\ 0\\.019688744567028408\ \(0\)\
\-\ infarction\\:\\ 0\\.019084745600153497\ \(0\)\
\-\ photon\\:\\ 0\\.01876942151615078\ \(0\)\
\-\ pressure\\:\\ 0\\.01833843120121497\ \(0\)\
\-\ base\\:\\ 0\\.01829212176410583\ \(0\)\
\-\ computer\\:\\ 0\\.017794899811400144\ \(0\)\
\-\ reversed\\:\\ 0\\.017794899811400144\ \(0\)\
\-\ cardiac\\:\\ 0\\.017785993404103664\ \(0\)\
\-\ thirty\\:\\ 0\\.017296753481362014\ \(0\)\
\-\ gated\\:\\ 0\\.017296753481362014\ \(0\)\
\-\ circular\\:\\ 0\\.017296753481362014\ \(0\)\
\-\ calculated\\:\\ 0\\.016875576760522513\ \(0\)\
\-\ twenty\\:\\ 0\\.01618892531713206\ \(0\)\
\-\ tomographic\\:\\ 0\\.016041200668852618\ \(0\)\
\-\ dual\\:\\ 0\\.015901055055771877\ \(0\)\
\-\ fraction\\:\\ 0\\.015901055055771877\ \(0\)\
\-\ inferior\\:\\ 0\\.01584325880524078\ \(0\)\
\-\ alteration\\:\\ 0\\.015767748596292555\ \(0\)\
\-\ minute\\:\\ 0\\.015519191825238657\ \(0\)\
\-\ reviewed\\:\\ 0\\.015519191825238657\ \(0\)\
\-\ global\\:\\ 0\\.015519191825238657\ \(0\)\
\-\ ejection\\:\\ 0\\.015184212803128459\ \(0\)\
\-\ specificity\\:\\ 0\\.015184212803128459\ \(0\)\
\-\ bpm\\:\\ 0\\.015081097152902102\ \(0\)\
\-\ revealed\\:\\ 0\\.014986196119486848\ \(0\)\
\-\ corresponds\\:\\ 0\\.014885854081912633\ \(0\)\
\-\ 2\\.\\:\\ 0\\.01484942153989212\ \(0\)\
\-\ 1\\.\\:\\ 0\\.014585733149167217\ \(0\)\
\-\ image\\:\\ 0\\.014585733149167217\ \(0\)\
\-\ injected\\:\\ 0\\.014451251091121138\ \(0\)\
\-\ allow\\:\\ 0\\.014451251091121138\ \(0\)\
\-\ initiated\\:\\ 0\\.014372050170702417\ \(0\)\
\-\ prompt\\:\\ 0\\.014372050170702417\ \(0\)\
\-\ severe\\:\\ 0\\.014367813115114777\ \(0\)\
\-\ mmhg\\:\\ 0\\.014220219976290365\ \(0\)\
\-\ techniques\\:\\ 0\\.01393974414552511\ \(0\)\
\-\ manipulation\\:\\ 0\\.013873903840664288\ \(0\)\
\-\ baseline\\:\\ 0\\.013809612864133703\ \(0\)\
\-\ remote\\:\\ 0\\.013509063970105485\ \(0\)\
\-\ fixed\\:\\ 0\\.013509063970105485\ \(0\)\
\-\ 71\\:\\ 0\\.013509063970105485\ \(0\)\
\-\ apical\\:\\ 0\\.013452727119824785\ \(0\)\
\-\ images\\:\\ 0\\.013436589278273394\ \(0\)\
\-\ monitor\\:\\ 0\\.013290368047500192\ \(0\)\
\-\ following\\:\\ 0\\.013252883917492613\ \(0\)\
\-\ sensitivity\\:\\ 0\\.013187252397273835\ \(0\)\
\-\ systolic\\:\\ 0\\.01299200932628437\ \(0\)\
\-\ monitoring\\:\\ 0\\.012899382135913656\ \(0\)\
\-\ correlation\\:\\ 0\\.012854220108724555\ \(0\)\
\-\ blood\\:\\ 0\\.012745415696772127\ \(0\)\
\-\ septal\\:\\ 0\\.012723047378707174\ \(0\)\
\-\ computed\\:\\ 0\\.012326375220662098\ \(0\)\
\-\ frequency\\:\\ 0\\.012326375220662098\ \(0\)\
\-\ deficit\\:\\ 0\\.012045899389896845\ \(0\)\
\-\ \\(\\:\\ 0\\.011841995512194435\ \(0\)\
\-\ assess\\:\\ 0\\.01170196429183946\ \(0\)\
\-\ \\)\\:\\ 0\\.011697339214972215\ \(0\)\
\-\ by\\:\\ 0\\.011662876256105532\ \(0\)\
\-\ different\\:\\ 0\\.01155888236419652\ \(0\)\
\-\ color\\:\\ 0\\.011396523291871928\ \(0\)\
\-\ place\\:\\ 0\\.01134447904331812\ \(0\)\
\-\ observed\\:\\ 0\\.011194042493637714\ \(0\)\
\-\ imaging\\:\\ 0\\.010940294122708211\ \(0\)\
\-\ current\\:\\ 0\\.010938071225666887\ \(0\)\
\-\ injection\\:\\ 0\\.010894001876131687\ \(0\)\
\-\ \\%\\:\\ 0\\.010892464663092937\ \(0\)\
\-\ ischemia\\:\\ 0\\.010850632069693736\ \(0\)\
\-\ was\\:\\ 0\\.010800847237308052\ \(0\)\
\-\ 45\\:\\ 0\\.010786841457680097\ \(0\)\
\-\ deficits\\:\\ 0\\.010683725807453739\ \(0\)\
\-\ were\\:\\ 0\\.010602657577540553\ \(0\)\
\-\ visual\\:\\ 0\\.010584360659445886\ \(0\)\
\-\ left\\:\\ 0\\.01044923791555098\ \(0\)\
\-\ reveal\\:\\ 0\\.010395855546093558\ \(0\)\
\-\ please\\:\\ 0\\.01035966640196782\ \(0\)\
\-\ \\'s\\:\\ 0\\.010295336712388223\ \(0\)\
\-\ 14\\:\\ 0\\.01028869512764197\ \(0\)\
\-\ using\\:\\ 0\\.010135445218759337\ \(0\)\
\-\ review\\:\\ 0\\.01011893616286873\ \(0\)\
\-\ \\-\\:\\ 0\\.0100094451295539\ \(0\)\
\-\ before\\:\\ 0\\.009882572111204024\ \(0\)\
\-\ shortness\\:\\ 0\\.009822848630842004\ \(0\)\
\-\ procedure\\:\\ 0\\.009778897434799315\ \(0\)\
\-\ mid\\:\\ 0\\.00976440275657611\ \(0\)\
\-\ respiratory\\:\\ 0\\.00969306083306877\ \(0\)\
\-\ 9\\:\\ 0\\.009651133047072432\ \(0\)\
\-\ single\\:\\ 0\\.00946355270625801\ \(0\)\
\-\ rate\\:\\ 0\\.009100331941190828\ \(0\)\
\-\ the\\:\\ 0\\.009065526865811527\ \(0\)\
\-\ second\\:\\ 0\\.008967565396827809\ \(0\)\
\-\ breath\\:\\ 0\\.008729829394123902\ \(0\)\
\-\ year\\-old\\:\\ 0\\.008575859622126274\ \(0\)\
\-\ dilated\\:\\ 0\\.00848385630216292\ \(0\)\
\-\ presence\\:\\ 0\\.008474824094145161\ \(0\)\
\-\ calcification\\:\\ 0\\.008474824094145161\ \(0\)\
\-\ later\\:\\ 0\\.008430105576483398\ \(0\)\
\-\ \\,\\:\\ 0\\.008136094865273663\ \(0\)\
\-\ heart\\:\\ 0\\.008112239477892825\ \(0\)\
\-\ recent\\:\\ 0\\.007848959149835511\ \(0\)\
\-\ \\>\\:\\ 0\\.007757288291444165\ \(0\)\
\-\ a\\:\\ 0\\.007585242111284724\ \(0\)\
\-\ while\\:\\ 0\\.007346036174459873\ \(0\)\
\-\ during\\:\\ 0\\.007144834016185268\ \(0\)\
\-\ some\\:\\ 0\\.007089967906739779\ \(0\)\
\-\ patient\\:\\ 0\\.007021245335380229\ \(0\)\
\-\ 6\\:\\ 0\\.006973005905395831\ \(0\)\
\-\ decreased\\:\\ 0\\.006941957384493332\ \(0\)\
\-\ history\\:\\ 0\\.006449259768891166\ \(0\)\
\-\ at\\:\\ 0\\.006326574605637339\ \(0\)\
\-\ mild\\:\\ 0\\.0061482334806861666\ \(0\)\
\-\ is\\:\\ 0\\.006145254408576236\ \(0\)\
\-\ these\\:\\ 0\\.006076078393327432\ \(0\)\
\-\ of\\:\\ 0\\.006048011516835465\ \(0\)\
\-\ patients\\:\\ 0\\.006042553550180399\ \(0\)\
\-\ anterior\\:\\ 0\\.006013095146892725\ \(0\)\
\-\ for\\:\\ 0\\.005976296300350124\ \(0\)\
\-\ symptoms\\:\\ 0\\.005818736275677976\ \(0\)\
\-\ none\\:\\ 0\\.005791583352207668\ \(0\)\
\-\ consistent\\:\\ 0\\.005724858658008752\ \(0\)\
\-\ increased\\:\\ 0\\.00571170705409742\ \(0\)\
\-\ contrast\\:\\ 0\\.005226163078710124\ \(0\)\
\-\ may\\:\\ 0\\.005121115762016732\ \(0\)\
\-\ but\\:\\ 0\\.004979517215938627\ \(0\)\
\-\ findings\\:\\ 0\\.004969499824562731\ \(0\)\
\-\ after\\:\\ 0\\.004830604378713668\ \(0\)\
\-\ has\\:\\ 0\\.00438442614889147\ \(0\)\
\-\ which\\:\\ 0\\.004358318544378548\ \(0\)\
\-\ male\\:\\ 0\\.0042218730543373585\ \(0\)\
\-\ on\\:\\ 0\\.003955688592160809\ \(0\)\
\-\ and\\:\\ 0\\.003934623076114065\ \(0\)\
\-\ normal\\:\\ 0\\.003660143318576779\ \(0\)\
\-\ to\\:\\ 0\\.003500558265926117\ \(0\)\
\-\ there\\:\\ 0\\.0034746326679371276\ \(0\)\
\-\ in\\:\\ 0\\.003454075656887336\ \(0\)\
\-\ an\\:\\ 0\\.003228592525368114\ \(0\)\
\-\ \\:\\:\\ 0\\.003088182557351544\ \(0\)\
\-\ or\\:\\ 0\\.002736400953452753\ \(0\)\
\-\ this\\:\\ 0\\.0026260579598746804\ \(0\)\
\-\ no\\:\\ 0\\.0023509403024694043\ \(0\)\
\-\ with\\:\\ 0\\.0019181012473752416\ \(0\)\
\-\ \\.\\:\\ 0\\.0018428720924851892\ \(0\)\
